Profiel
Gene Liau worked as an Executive Director and Head of External R&D Rare Disease at Pfizer Inc. from 2011 to 2015.
He then worked as Senior Vice President and Head of Gene Therapy R&D at Precision BioSciences, Inc. from 2015 to 2017.
Prior to that, he was a Professor at The George Washington University Medical Center from 1995 to 2000.
Currently, he is the Chief Scientific Officer at Stoke Therapeutics, Inc. from 2018 to 2022.
He also worked as a Senior Scientist at Jerome H Holland Laboratory.
Dr. Liau holds a doctorate degree from Vanderbilt University and an undergraduate degree from The University of North Carolina at Chapel Hill, which he received in 1977.
Eerdere bekende functies van Gene Liau
Bedrijven | Functie | Einde |
---|---|---|
STOKE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-04-2022 |
PRECISION BIOSCIENCES, INC. | Corporate Officer/Principal | 01-08-2017 |
PFIZER, INC. | Director/Board Member | 01-06-2015 |
The George Washington University Medical Center | Corporate Officer/Principal | 01-01-2000 |
Jerome H Holland Laboratory | Corporate Officer/Principal | - |
Opleiding van Gene Liau
Vanderbilt University | Doctorate Degree |
The University of North Carolina at Chapel Hill | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
PFIZER, INC. | Health Technology |
PRECISION BIOSCIENCES, INC. | Health Technology |
STOKE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
The George Washington University Medical Center | |
Jerome H Holland Laboratory |